The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: summary of the scientific assessment of the Committee for Medicinal Products f (Q37949786)
Jump to navigation
Jump to search
scientific article published on 24 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: summary of the scientific assessment of the Committee for Medicinal Products f |
scientific article published on 24 October 2011 |
Statements
1 reference
The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: summary of the scientific assessment of the Committee for Medicinal Products f (English)
1 reference
Zahra Hanaizi
1 reference
Barbara van Zwieten-Boot
1 reference
Gonzalo Calvo
1 reference
Arantxa Sancho Lopez
1 reference
Maaike van Dartel
1 reference
Jorge Camarero
1 reference
Eric Abadie
1 reference
Francesco Pignatti
1 reference
24 October 2011
1 reference
1 reference
48
1 reference
2
1 reference
237-242
1 reference
Identifiers
1 reference
1 reference